Sofitel Hotel, Philadelphia, PA USA
Sep 20 2011 8:00AM - Sep 21 2011 5:00PM
Pharmacogenetic and biomarker research is rapidly progressing to enable understanding of human disease and drug response. During clinical drug development, the pharmaceutical industry commonly requests collection of samples for future research in order to investigate important new emergent scientific findings on how drugs relate to human health and disease. These include studies to explore mechanisms of drug action, response to therapies, and adverse events or to research subpopulations that emerge during clinical trials. However, considerable challenges exist to the collection of future use samples. Meet with global industry, regulatory and academic leaders to investigate the current barriers to the optimal collection of samples for future research related to drug response or disease characterization. Identify best practices and needed actions to improve current global collection of future use samples in clinical trials. This conference will be divided into 3 working sessions to look at key issues for future use sample collection in Japan, Europe, and the US/Canada Event Code:
11032
|